Monday, October 19th, 2020
10am New York | 3pm London | 4pm Berlin | 7:30pm Mumbai
Scientific manuscripts often spend months, sometimes years, in the hands of a restricted number of reviewers and editors before they are ultimately released to the rest of the scientific community after peer review. In recent years, the growing usage of preprints in the life sciences has revolutionized the publishing system by allowing the separation of the communication of scientific discoveries from their assessment by scientists, editors and journals. Despite a growing interest in the concept of preprints, asymmetries in their usage still exist across the scientific community, with certain geographical areas and research fields more active than others. During this event we will reflect on the status of preprints in life sciences and what their future evolution may look like. We will discuss what factors will influence a wider and more efficient adoption of preprints, and how to maximize their benefits for the whole scientific community.
Topics will include
Benefits and concerns about the use of preprints in the life sciences
Acceptance by the scientific community and funding agencies
Participation and diversity in research communication: do preprints address or contribute to disparities?
Alternative peer review models in the context of preprints
Panelists:
Chairs: Marco Fumasoni (Harvard University) and Yamini Ravichandran (Institut Pasteur/Institut Curie)
- Anjana Badrinarayan, NCBS-Bangalore, Principal Investigator
- Ross Mounce, Arcadia Fund
- Antonis Rokas, Vanderbilt School of Medicine, Principal Investigator
- Richard Sever, Co-founder of bioRxiv & medRxiv, Assistant Director of Cold Spring Harbor Laboratory Press
- Sowmya Swaminathan, Head of Editorial Policy & Research Integrity, Nature Research
Organized by ASAPbio Fellows: Yamini Ravichandran (Institut Pasteur/Institut Curie, France), Marco Fumasoni (Harvard University, US), Bradly Alicea (Orthogonal Research and Education Lab, US) and Sarah Stryeck (Graz University of Technology, Austria).
Registration is free but required!
Register now!
Monday, October 19th, 2020
10am New York | 3pm London | 4pm Berlin | 7:30pm Mumbai
Scientific manuscripts often spend months, sometimes years, in the hands of a restricted number of reviewers and editors before they are ultimately released to the rest of the scientific community after peer review. In recent years, the growing usage of preprints in the life sciences has revolutionized the publishing system by allowing the separation of the communication of scientific discoveries from their assessment by scientists, editors and journals. Despite a growing interest in the concept of preprints, asymmetries in their usage still exist across the scientific community, with certain geographical areas and research fields more active than others. During this event we will reflect on the status of preprints in life sciences and what their future evolution may look like. We will discuss what factors will influence a wider and more efficient adoption of preprints, and how to maximize their benefits for the whole scientific community.
Topics will include
Benefits and concerns about the use of preprints in the life sciences
Acceptance by the scientific community and funding agencies
Participation and diversity in research communication: do preprints address or contribute to disparities?
Alternative peer review models in the context of preprints
Panelists:
Chairs: Marco Fumasoni (Harvard University) and Yamini Ravichandran (Institut Pasteur/Institut Curie)
Organized by ASAPbio Fellows: Yamini Ravichandran (Institut Pasteur/Institut Curie, France), Marco Fumasoni (Harvard University, US), Bradly Alicea (Orthogonal Research and Education Lab, US) and Sarah Stryeck (Graz University of Technology, Austria).
Registration is free but required!
Register now!